Insiders Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Market Closed - Nasdaq Other stock markets 16:30:01 2024-06-28 EDT			5-day change	1st Jan Change
3.21 ^USD	-2.43%		+2.23%	-75.20%

05-15	Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	Windtree Therapeutics Seeks Acquisitions	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Principal Financial Officer	02-16	CI
Windtree Therapeutics, Inc. Appoints Jamie McAndrew as Controller, Chief Accounting Officer and Principal Accounting Officer	23-08-28	CI
Windtree Therapeutics, Inc. Appoints Mark Strobeck to its Board of Directors	23-06-27	CI
Windtree Therapeutics Chair James Huang Resigns; Shares Sink Premarket	23-04-19	MT
Windtree Therapeutics, Inc. Announces Chief Financial Official Officer Changes	23-01-19	CI
Windtree Therapeutics, Inc. Announces Executive Changes	23-01-19	CI
Windtree Therapeutics, Inc. Announces Not Stand for Re-Election of Evan Loh from Board	22-05-11	CI
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel	21-07-01	CI
Windtree Therapeutics, Inc. Announces Bruce Peacock, A Member of the Board of Directors Not to Stand for Re-Election	21-04-30	CI
Insider Trends: Windtree Therapeutics Insider Buy Scaling Back 90-Days of Sells	21-04-02	MT
Windtree Therapeutics, Inc. Announces Executive Changes	21-02-04	CI
Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development	21-02-01	CI
Windtree Therapeutics, Inc. Announces Executive Appointment	20-07-21	CI
Windtree Therapeutics, Inc. Appoints John Hamill as Senior Vice President	20-07-20	CI
Windtree Therapeutics, Inc. Appoints John Hamill as Chief Financial Officer	20-07-20	CI
Windtree Therapeutics, Inc. Appoints Eric Curtis as Senior Vice President and Chief Operating Officer	20-03-13	CI
Windtree Therapeutics, Inc. Appoints Daniel Geffken to its Board of Directors	19-04-30	CI
Windtree Therapeutics, Inc. Announces Executive Appointments	18-12-21	CI
Windtree Therapeutics, Inc. Announces Demise of Marvin E. Rosenthale, Chairman of the Board's Nomination and Governance Committee and a Member of the Audit Committee	18-08-16	CI
Discovery Laboratories, Inc. has Changed its Name to Windtree Therapeutics, Inc	16-04-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Insiders

Filters